Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rectal Neoplasms × Tablets × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Uterine Neoplasms 1 Rectal Neoplasms 1 Pregnancy Complications 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Leiomyoma 1 Infertility, Female 1 Genetic Diseases, Inborn 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Fluorouracil 14 Capecitabine 14 Oxaliplatin 11 Leucovorin 10 Nivolumab 9 Cetuximab 9 Radiotherapy 8 Magnetic Resonance Spectroscopy 6 pembrolizumab 5 Irinotecan 5 encorafenib 4 Surgical Procedures, Operative 4 Sigmoidoscopy 4 Radiotherapy, Intensity-Modulated 4 Bevacizumab 4 Specimen Handling 3 Biopsy 3 trifluridine tipiracil drug combination 2 regorafenib 2 dostarlimab 2 dehydroftorafur 2 atezolizumab 2 XELOX 2 X-Rays 2 Trifluridine 2 Surveys and Questionnaires 2 Standard of Care 2 Pemetrexed 2 Observation 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04503694 2026-03-27

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡